1. |
|
dni-hmn:lym 20 mg/L
|
|
INNDDK Investigational New Drugs. The Journal of New Anticancer Agents. 1 (1983),283. |
2. |
|
oms-hmn:lym 20 mg/L
|
|
INNDDK Investigational New Drugs. The Journal of New Anticancer Agents. 1 (1983),283. |
3. |
|
mnt-mus-ipr 200 mg/kg
|
|
BJCAAI British Journal of Cancer. 52 (1985),725. |
4. |
|
cyt-ham-orl 100 mg/kg
|
|
BJCAAI British Journal of Cancer. 52 (1985),725. |
5. |
|
orl-man TDLo:693 mg/kg/77W-I:CAR
|
|
LANCAO Lancet. 2 (1981),1343. |
6. |
|
orl-wmn TD:4650 mg/kg/2Y-C:CAR
|
|
LANCAO Lancet. 2 (1981),1343. |
7. |
|
orl-wmn TDLo:3650 mg/kg/2Y-I:BLD
|
|
LANCAO Lancet. 2 (1987),1085. |
8. |
|
unr-wmn TDLo:600 mg/kg/34W-I:BLD
|
|
BJDEAZ British Journal of Dermatology. 113 (1985),131. |
9. |
|
unr-man TDLo:6467 mg/kg/6Y-I:BLD
|
|
BJDEAZ British Journal of Dermatology. 113 (1985),131. |
10. |
|
ipr-mus LD50:500 mg/kg
|
|
CPBTAL Chemical and Pharmaceutical Bulletin. 29 (1981),1594. |